Nugenerex Immuno-Oncology, of Miramar, Fla., a unit of Generex Biotechnology Corp., closed its previously-announced licensing and distribution agreement with Bintai Kinden Corp., of Malaysia, to develop and commercialize Ii-Key-SARS-CoV-2 coronavirus vaccine.

https://www.bioworld.com/articles/498681-othe...oct-7-2020